Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER in painful diabetic peripheral neuropathy
NCT01041859Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tapentadol in diabetic peripheral neuropathy (DPN), sponsored by Johnson & Johnson. Started Dec 2009; status: completed.
02
Drugs
tapentadol
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01041859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041859.